#wegovy
#wegovy

Long-term Wegovy study finds weight loss plateaus a little after a year

Weight loss on Wegovy plateaus after 65 weeks but is maintained over 4 years with a significant difference from the placebo group. [ more ]

WIRED

21 hours ago

Medicine

Wegovy Can Keep Weight Off for at Least 4 Years, Research Shows

People on Wegovy experience steady weight loss for 65 weeks, maintaining initial loss over 4 years despite hitting a plateau. [ more ]

www.nytimes.com

3 weeks ago

Opinion | This Is What a Miracle Drug Looks Like. And It Only Costs $5 to Make.

GLP-1 drugs like Ozempic and Wegovy have significant impact on weight loss and reducing the risk of heart disease, stroke, and other comorbidities. [ more ]

www.fastcompany.com

3 months ago

Could weight-loss drugs like Ozempic cause depressionor help treat it?

GLP-1s, a drug class used for diabetes and weight loss, could potentially be effective in treating neurological conditions.

Wegovy and Ozempic, both containing semaglutide, have shown benefits beyond weight loss and heart protection. [ more ]

Entrepreneur

Does Wegovy Work for Longterm Weight Loss? New Study Says Yes | Entrepreneur

Wegovy leads to 10% weight loss maintenance over four years for obesity patients without diabetes. [ more ]

Fast Company

2 weeks ago

Business

25,000 people begin taking Wegovy each week, but Novo Nordisk stock is sinking anyway

Novo Nordisk's significant increase in Wegovy users and sales shows a growing demand for weight loss drugs. [ more ]

London Business News | Londonlovesbusiness.com

2 weeks ago

Business

Novo Nordisk Q1 results: 'Strong performance' and 'rosy outlook' expected

Investment in Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic led to record growth in Q4 2023. [ more ]

morenovo-nordisk

www.scientificamerican.com

3 weeks ago

New Weight-Loss Drugs Are Meant to Be Lifelong. What Happens When You Quit?

Weight-loss drugs like Wegovy and Ozempic are popular but many users quit due to factors like cost, side effects, and limited coverage. [ more ]

fda-approval

Entrepreneur

Is Wegovy Covered By Insurance? These Insurers Offer Coverage | Entrepreneur

Major health insurance companies in the U.S. are starting to cover Novo Nordisk's weight loss injection Wegovy.

The FDA approved Wegovy for heart health after a study showed it could reduce the risk of heart attack and stroke by 20%. [ more ]

www.npr.org

Medicare plans can now cover Wegovy for patients at risk of heart disease

Medicare to cover the obesity drug Wegovy for preventing heart attacks and strokes

Medicare guidance allows coverage for FDA-approved anti-obesity medications with additional benefits [ more ]

ABC7 San Francisco

Does Medicare cover Wegovy? Insurance provider could start covering certain weight loss drugs

Medicare may cover Wegovy for certain beneficiaries with heart disease.

CMS guidance allows using FDA-approved medications for specific uses under Part D plans. [ more ]

www.scientificamerican.com

The FDA recently approved semaglutide (Wegovy) for preventing serious heart conditions in some people, but questions remain about how it works

Semaglutide (Wegovy) approved by FDA to prevent serious cardiovascular conditions for high-risk individuals

The approval expands the use of semaglutide to overweight or obese individuals with a history of cardiac events [ more ]

www.fastcompany.com

Wegovy is no longer just a weight-loss drug

Wegovy was approved by the FDA to reduce the risk of major cardiovascular events in obese or overweight adults with established cardiovascular disease.

Wegovy has been shown to reduce the risk of major adverse cardiac events by 20%, cardiovascular death by 15%, and death from any cause by 19%. [ more ]

www.nytimes.com

Wegovy Moves Beyond Weight Loss

Wegovy now approved for reducing cardiovascular risks in adults with heart disease and obesity

F.D.A. approval based on study showing Wegovy reduced heart attacks and strokes [ more ]

morefda-approval

www.npr.org

1 week ago

Decades-old law limits access to Wegovy for Medicaid beneficiaries

Medicaid plans not required to cover Wegovy for weight loss/obesity, despite effectiveness, due to old law. [ more ]

Futurism

Medicare Will Start Paying for Wegovy

Medicare may cover weight-loss drug Wegovy for select members with heart disease history

Wegovy assists in weight loss and reduces cardiovascular risk by around 20% [ more ]

www.npr.org

FDA approves Wegovy for lowering heart attack and stroke risk in overweight patients

Weight-loss drug Wegovy approved to reduce cardiovascular risk in overweight patients.

Wegovy can lower the risk of heart attacks, strokes, and heart-related deaths in patients with obesity. [ more ]

time.com

Wegovy Is Good for More Than Just Weight Loss

Wegovy lowers cardiovascular risks in obese individuals with heart disease by 20%

Obesity drug Wegovy is a significant advancement in weight loss medication [ more ]

The Atlantic

6 months ago

The Obesity-Drug Era Starts Now

Obesity drugs like Wegovy are becoming more accessible to patients and may become a routine part of healthcare.

A recent study shows that Wegovy can have profound effects on heart health, opening up the drug to more patients.

The FDA has approved another obesity drug, Zepbound, which may be more potent and cheaper than Wegovy. [ more ]

The Atlantic

6 months ago